IKS Health Acquihires ThinkDTM To Expand Patient Access Team

03 Apr 2026 CW Team

Bedi and his colleagues will lead the strategic expansion, scaling and transformation of patient scheduling, registration, demographic capture, insurance eligibility verification and prior authorisations. The team will focus on building and scaling differentiated patient access solutions, strengthening platform capabilities and driving forward-looking innovation that improves outcomes for healthcare providers and those they serve. The work will include integrating advanced automation and machine learning into workflows to reduce administrative burdens and speed patient throughput.

IKS will pursue strategic partnerships to leverage the novel applications of AI and product design expertise to create differentiated market opportunities. Company leadership emphasised that the new team enhances capabilities in agentic AI and human-in-the-loop approaches, which the firm sees as central to continued growth in revenue optimisation and operational performance. The integration is expected to support scalable deployment of solutions across client networks.

Founded in 2006, IKS operates a Care Enablement platform that integrates agentic AI workflows with human expertise to create smarter, more accurate operations, better clinical and financial outcomes, and sustainable growth across the care journey. The company has received recognition from industry surveys and awards for its performance in AI-driven revenue cycle management and client satisfaction and has been cited by technology partners for augmenting human expertise with AI. IKS serves large health systems, physician groups and speciality practices across the United States.

"Join industry leaders at RAHSTA Expo, India's premier platform for roads, highways and traffic infrastructure. Register now to explore innovations, network with experts and shape the future of mobility."

IKS Health (IKS) has completed an acquihire of ThinkDTM, an AI-native product, strategy and digital services company, in a move to expand its patient access capabilities. The transaction, announced on 31 March 2026, brings ThinkDTM founder Tij Bedi into the company as Executive Vice President and General Manager, Patient Access and Innovation, and integrates his team of AI technology experts into IKS. The addition is intended to accelerate the firm’s ability to implement AI-driven solutions across patient access functions. Bedi and his colleagues will lead the strategic expansion, scaling and transformation of patient scheduling, registration, demographic capture, insurance eligibility verification and prior authorisations. The team will focus on building and scaling differentiated patient access solutions, strengthening platform capabilities and driving forward-looking innovation that improves outcomes for healthcare providers and those they serve. The work will include integrating advanced automation and machine learning into workflows to reduce administrative burdens and speed patient throughput. IKS will pursue strategic partnerships to leverage the novel applications of AI and product design expertise to create differentiated market opportunities. Company leadership emphasised that the new team enhances capabilities in agentic AI and human-in-the-loop approaches, which the firm sees as central to continued growth in revenue optimisation and operational performance. The integration is expected to support scalable deployment of solutions across client networks. Founded in 2006, IKS operates a Care Enablement platform that integrates agentic AI workflows with human expertise to create smarter, more accurate operations, better clinical and financial outcomes, and sustainable growth across the care journey. The company has received recognition from industry surveys and awards for its performance in AI-driven revenue cycle management and client satisfaction and has been cited by technology partners for augmenting human expertise with AI. IKS serves large health systems, physician groups and speciality practices across the United States.

Real Estate

07 Jul 2026

Pecan Realty Completes Rs 1.5 Billion Transactions

Pecan Realty has recently completed four institutional transactions worth over Rs 1.5 billion over the past two years, strengthening its position as an execution-led real estate platform. The deals include resolution-led acquisitions, structured finance transactions and capital partnerships across its development portfolio.The transactions covered acquisitions through the National Company Law Tribunal process and helped provide repayment or exits to both private and public sector lenders. The company said the deals demonstrate its ability to resolve complex project situations, work with instit..

Real Estate

07 Jul 2026

SNN Estates Expands North Bengaluru Housing Project

SNN Estates has announced an expansion of its SNN Estates Felicity residential project in North Bengaluru following strong buyer demand, with 75 per cent of the first-phase inventory sold within three days of launch.The developer will add 76 apartments in the new phase, taking the project's estimated revenue potential to around Rs 1,000 crore upon completion of Phase 2.Spread across 6.5 acres in Rachenahalli, near Manyata Tech Park, the project comprises 604 apartments in 1.5, 2, 2.5, 3 and 4 BHK configurations. The development includes a 50,000-sq-ft clubhouse with amenities such as sports co..

Infrastructure Urban

07 Jul 2026

SCG Drives ASEAN Industrial Transformation Strategy

SCG is strengthening its focus on ASEAN as a key growth region by advancing industrial transformation, enhancing competitiveness and building resilient regional value chains. Thammasak Sethaudom, President and Chief Executive Officer, SCG, highlighted the need for industries to continuously develop capabilities, strengthen resilience and deepen regional cooperation to achieve sustainable long-term growth.SCG views ASEAN as an important growth engine alongside China, supported by favourable demographics, trade connectivity and investment flows. With ASEAN’s GDP projected to grow by around 4.7..